PTPI 8-K 2026-06-18

Petros Pharmaceuticals, Inc. (PTPI) 8-K dated 2026-06-18 — accession 0001104659-26-075849.

Petros Pharmaceuticals, Inc. (PTPI) is a drug manufacturers - specialty & generic company listed on US.

Petros Pharmaceuticals, Inc. filed a 8-K on 2026-06-18. Accession 0001104659-26-075849.

This 8-K covers: Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PTPI revenue for 2024-12-31 was $5.1M. Net income was -$14.3M. Revenue was down 14.7% from 2022-12-31 to 2024-12-31. PTPI currently screens at market cap $233.0K.

Not investment advice. The PTPI SEC hub lists recent forms. The stock page is the research view.